Correlation Between Pmv Pharmaceuticals and Tyra Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and Tyra Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and Tyra Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and Tyra Biosciences, you can compare the effects of market volatilities on Pmv Pharmaceuticals and Tyra Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of Tyra Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and Tyra Biosciences.

Diversification Opportunities for Pmv Pharmaceuticals and Tyra Biosciences

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pmv and Tyra is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and Tyra Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tyra Biosciences and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with Tyra Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tyra Biosciences has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and Tyra Biosciences go up and down completely randomly.

Pair Corralation between Pmv Pharmaceuticals and Tyra Biosciences

Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.47 times more return on investment than Tyra Biosciences. However, Pmv Pharmaceuticals is 2.12 times less risky than Tyra Biosciences. It trades about 0.09 of its potential returns per unit of risk. Tyra Biosciences is currently generating about -0.06 per unit of risk. If you would invest  151.00  in Pmv Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  18.00  from holding Pmv Pharmaceuticals or generate 11.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pmv Pharmaceuticals  vs.  Tyra Biosciences

 Performance 
       Timeline  
Pmv Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Pmv Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Tyra Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tyra Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pmv Pharmaceuticals and Tyra Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pmv Pharmaceuticals and Tyra Biosciences

The main advantage of trading using opposite Pmv Pharmaceuticals and Tyra Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, Tyra Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tyra Biosciences will offset losses from the drop in Tyra Biosciences' long position.
The idea behind Pmv Pharmaceuticals and Tyra Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum